Pharnext (France) Executives
| ALPHA Stock | EUR 0.0002 0.00 0.00% |
Pharnext employs about 28 people. The company is managed by 11 executives with a total tenure of roughly 66 years, averaging almost 6.0 years of service per executive, having 2.55 employees per reported executive. Discussion of Pharnext's management performance can provide insight into the enterprise performance.
| Joshua Schafer Insider Interim Chairman |
| Xavier MSc Insider Chief Officer |
Pharnext |
Pharnext Management Team Effectiveness
The company has return on total asset (ROA) of (0.7578) % which means that it has lost $0.7578 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (13.4844) %, meaning that it generated substantial loss on money invested by shareholders. Pharnext's management efficiency ratios could be used to measure how well Pharnext manages its routine affairs as well as how well it operates its assets and liabilities.Pharnext Workforce Comparison
Pharnext SA is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 224,253. Pharnext adds roughly 28.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Pharnext SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Pharnext SA Price Series Summation is a cross summation of Pharnext price series and its benchmark/peer.
Pharnext Notable Stakeholders
A Pharnext stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pharnext often face trade-offs trying to please all of them. Pharnext's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pharnext's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Joshua Schafer | Interim Chairman | Profile | |
| Xavier MSc | Chief Officer | Profile | |
| Rodolphe Hajj | Chief Officer | Profile | |
| Susanne Dorn | Chief Officer | Profile | |
| Daniel Cohen | Director | Profile | |
| DSc Chumakov | Chairman CoFounder | Profile | |
| Rob Quinn | Chief Officer | Profile | |
| Philippe Rinaudo | Chief Officer | Profile | |
| David MD | CEO Director | Profile | |
| Antoine Gravelle | G Counsel | Profile | |
| Viviane Bertrand | Chief Officer | Profile |
About Pharnext Management Performance
The success or failure of an entity such as Pharnext SA often depends on how effective the management is. Pharnext management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pharnext management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pharnext management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Pharnext SA, a clinical-stage biopharmaceutical company, develops therapeutics for severe orphan and common neurodegenerative diseases in France. The company was founded in 2007 and is based in Issy-Les-Moulineaux, France. Pharnext S is traded on Paris Stock Exchange in France.
Pharnext Workforce Analysis
Traditionally, organizations such as Pharnext use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pharnext within its industry.Pharnext Manpower Efficiency
Return on Pharnext Manpower
| Revenue Per Employee | 3K | |
| Revenue Per Executive | 7.7K | |
| Net Loss Per Employee | 1.1M | |
| Net Loss Per Executive | 2.8M |
Additional Tools for Pharnext Stock Analysis
When running Pharnext's price analysis, check to measure Pharnext's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharnext is operating at the current time. Most of Pharnext's value examination focuses on studying past and present price action to predict the probability of Pharnext's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharnext's price. Additionally, you may evaluate how the addition of Pharnext to your portfolios can decrease your overall portfolio volatility.